Cited by 176Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers

Open access

Christiaans, Imke, van Engelen, Klaartje, van Langen, Irene M., Birnie, Erwin, Bonsel, Gouke J., Elliott, Perry M., Wilde, Arthur A.M.·2010·EP Europace

DOI 10.1093/europace/eup431

Open this paper in CoChat — free account

Abstract

We performed a systematic literature review of recommended 'major' and 'possible' clinical risk markers for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). We searched the Medline, Embase and Cochrane databases for articles published between 1971 and 2007. We included English language reports on HCM patients containing follow-up data on the endpoint (sudden) cardiac death using survival analysis. Analysis was undertaken using the quality of reporting of meta-analyses (QUORUM) statement checklist. The quality was checked using a quality assessment form from the Cochrane Collaboration. Thirty studies met inclusion criteria and passed quality assessment. The use of the six major risk factors (previous cardiac arrest or sustained ventricular tachycardia, non-sustained ventricular tachycardia, extreme left ventricular hypertrophy, unexplained syncope, abnormal blood pressure response, and family history of sudden death) in risk stratification for SCD as recommended by international guidelines was supported by the literature. In addition, left ventricular outflow tract obstruction seems associated with a higher risk of SCD. Our systematic review provides sound evidence for the use of the six major risk factors for SCD in the risk stratification of HCM patients. Left ventricular outflow tract obstruction could be included in the overall risk profile of patients with a marked left ventricular outflow gradient under basal conditions.

Integrity signals

Registry

Crossref · 10.1093/europace/eup431

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Contemporary Definitions and Classification of the Cardiomyopathies
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C. N., Corrado, D., Arnett, D. K., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,424
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Elliot, P. M., Andersson, B., Arbustini, E., Bilińska, Z. T., Cecchi, F., Charron, P., Dubourg, O., Kühl, U., Maisch, B., McKenna, W. J., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm342 · Cited by 2,995
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
Maron, B. J., McKenna, W. J., Danielson, G. K., KAPPENBERGER, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,572
Hypertrophic Cardiomyopathy
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,276
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy
Spirito, P., Bellone, P., Harris, K. M., Bernabò, P., Bruzzi, P., & Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422403 · Cited by 1,142
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 776
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757

Flagged first, then by citations

Show all 69 references

1 of the 69 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–175 of 175

Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter–defibrillator using the 2014 European Society of Cardiology guidelines
Nakano, M., Kondo, Y., Nakano, M., Kajiyama, T., Miyazawa, K., Hayashi, T., Ito, R., Takahira, H., & Kobayashi, Y. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01668-z · Cited by 5
What Aspects of Phenotype Determine Risk for Sudden Cardiac Death in Pediatric Hypertrophic Cardiomyopathy?
Östman‐Smith, I. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9050124 · Cited by 5
Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement
Burban, A., Pucyło, S., Sikora, A., Opolski, G., Grabowski, M., & Kołodzińska, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713239 · Cited by 5
The differentiation of the competitive athlete with physiologic cardiac remodeling from the athlete with cardiomyopathy
Henning, R. J. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102473 · Cited by 5
Machine learning and physical based modeling for cardiac hypertrophy
Miličević, B., Milošević, M., Simić, V., Preveden, A., Velicki, L., Jakovljević, D. G., Bosnić, Z., Pičulin, M., Žunkovič, B., Kojić, M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16724 · Cited by 5
Was a mistake made when programmed electrical stimulation was eliminated as a sudden death risk marker in hypertrophic cardiomyopathy?
Monfredi, O., & Calkins, H. G. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.019 · Cited by 5
Sudden Cardiac Arrest in a Young Patient with Hypertrophic Cardiomyopathy and Zero Canonical Risk Factors: The Inherent Limitations of Risk Stratification in Hypertrophic Cardiomyopathy
Kohorst, J. J., Bos, J. M., Hagler, D. J., & Ackerman, M. J. (2013) · Congenital Heart Disease · doi:10.1111/chd.12073 · Cited by 4
Historical Perspectives on the Implantable Cardioverter–Defibrillator and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.03.001 · Cited by 4
Improved robust T-wave alternans detectors
Meste, O., Janusek, D., Karczmarewicz, S., Przybylski, A., Kania, M., Maciąg, A., & Maniewski, R. (2015) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-015-1243-5 · Cited by 4
Temas de actualidad en insuficiencia cardiaca
Colet, J. C., Aguilera, R. M., Castillo, J. J. C., & Delgado, J. F. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70044-2 · Cited by 4
Indications for implantable cardioverter defibrillator therapy, device, and lead selection
Cohen, M. I., & Etheridge, S. P. (2017) · Wiley eBooks · doi:10.1002/9781119333050.ch4 · Cited by 4
The ESC Risk Score Is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps Specificity
Maron, M. S., Rowin, E. J., & Maron, B. J. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.06.018 · Cited by 4
Extended ECG Monitoring in Patients with Hypertrophic Cardiomyopathy: The Tempo-HCM Study
Caro‐Codón, J., Castrejón‐Castrejón, S., Cádenas, R., Casanova, C., Vélez, A., Elorz, M. B., Lacuey, G., Climent, V. E., Salvador, O., Sánchez, A. S., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207432 · Cited by 3
Hypertrophic cardiomyopathy in adults: An overview
Jacobs, C. (2014) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12156 · Cited by 3
Newer risk assessment strategies in hypertrophic cardiomyopathy
Chaudhry‐Waterman, N., & Cohen, M. I. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000804 · Cited by 3
Can positron emission tomography help stratify the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy?
Kay, G. N. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-018-1299-3 · Cited by 3
Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging for non-sustained ventricular tachycardia and sudden cardiac death in hypertrophic cardiomyopathy: a meta-analysis
Siddiqi, A. K., Maniya, M. T., Bilen, O., Abdou, M. A. H., Cecco, C. N. D., & Naeem, M. (2025) · European Radiology · doi:10.1007/s00330-025-11961-y · Cited by 2
Electrophysiological fi ndings in Fabry cardiomyopathy: mapping the maze of risk stratifi cation
Li, J., Warth, A., Schnabel, P. A., Schweizer, P. A., Buss, S. J., Steen, H., Becker, R., Katus, H. A., & Thomas, D. (2012) · Acta cardiologica. Supplementum · doi:10.1080/ac.67.4.2170694 · Cited by 2
RISK CLASSIFICATION FOR SUDDEN CARDIAC DEATH IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY BASED ON MACHINE LEARNING ALGORITHMS
Pavić, O., Dašić, L., Geroski, T., Jovanović, M. V., & Filipović, N. (2022) · Journal of the Serbian Society for Computational Mechanics · doi:10.24874/jsscm.2023.17.02.11 · Cited by 2
Predictors of arrhythmic events in hypertrophic cardiomyopathy patients with an implantable cardioverter defibrillator: a systematic review and meta-analysis
Chiotis, S., Doundoulakis, I., Zgouridou, A., Piperis, C., Raptis, D. G., Peletidi, A., Vassilikou, A., Toumpourleka, M., Economou, F. I., Boulmpou, A., et al. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf021 · Cited by 2
Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention
Sarrias, A., Galve, E., Sabaté, X., Moya‐Mitjans, À., Anguera, I., Núñez, E., Villuendas, R., Alcalde, Ó., & David Garcia-dorado, A. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.06.025 · Cited by 2
Almanac 2011: Cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
Elliot, P. M., & MOHIDDIN, S. A. (2012) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2012.01.012 · Cited by 2
Almanac 2011: cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
Elliot, P. M., & MOHIDDIN, S. A. (2011) · Heart · doi:10.1136/heartjnl-2011-301266 · Cited by 2
ICD-Therapie zur Primärprävention
Wasmer, K., Köbe, J., Pott, C., & Eckardt, L. (2010) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-010-0079-9 · Cited by 2
Ventricular arrhythmias and sudden death in hypertrophic cardiomyopathy
Durdil, V. (2010) · Cor et Vasa · doi:10.33678/cor.2010.118 · Cited by 2
Heart Failure as a Consequence of Hypertrophic Cardiomyopathy
Marian, A. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00023-5 · Cited by 2
Ventricular arrhythmias complicating hypertrophic cardiomyopathy
Hutchings, D. C., Sankaranarayanan, R., & Venetucci, L. A. (2012) · British Journal of Hospital Medicine · doi:10.12968/hmed.2012.73.9.502 · Cited by 2
Almanac 2014: Cardiomyopathies.
Guttmann, O. P., MOHIDDIN, S. A., & Elliot, P. M. (2015) · Cardiologia Croatica · doi:10.15836/ccar.2014.543 · Cited by 2
Genetic Cardiomyopathies
Paranal, R. M., Teekakirikul, P., Ho, C. Y., Fatkin, D., & Seidman, C. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812532-8.00002-1 · Cited by 1
Prediction of sudden death in obstructive hypertrophic cardiomyopathy after septal myectomy: Targeting the candidate
Lu, T., Lu, Z., Meng, Y., Yang, Q., Cui, H. Z., Zhao, S., Song, Y., Zhu, C., & Wang, S. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.04.008 · Cited by 1
International Experience With Implantable Cardioverter Defibrillators for the Prevention of Sudden Death in High-Risk Patients With Hypertrophic Cardiomyopathy
Rowin, E. J., Maron, B. J., Siontis, K. C., Tower-Rader, A. F., Massera, D., Koethe, B. C., Bilen, O., Phelan, D., Arnold, A. D., Mohal, J. S., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.078597 · Cited by 1
Adolescent Chest Pain—Is It the Heart?
Selbst, S. M., Palermo, R. A., Durani, Y., & Giordano, K. (2011) · Clinical Pediatric Emergency Medicine · doi:10.1016/j.cpem.2011.09.009 · Cited by 1
Hypertrophic cardiomyopathy: An inherited cardiac condition
Elliott, K. (2010) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2010.5.10.78866 · Cited by 1
Hypertrophic Cardiomyopathy: Treatment, Risk Stratification, and Implantable Defibrillators
Magnusson, P. (2017) · InTech eBooks · doi:10.5772/65392 · Cited by 1
Ventricular Arrhythmias in Hypertrophic Cardiomyopathy
Issa, Z. F., Miller, J. M., & Zipes, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-1274-8.00028-2 · Cited by 1
Miocardiopatía hipertrófica: ¿cómo evaluamos en 2018 el riesgo de muerte súbita?
Estrada, A., Brenna, E. J., Contreras, A., Amuchástegui, M., Estrada, C., Caeiro, A. A., & Salomone, Ó. A. (2018) · Revista Uruguaya de Cardiología · doi:10.29277/cardio.33.3.20 · Cited by 1
Two rare variants in the MYBPC3 gene associated with familial hypertrophic cardiomyopathy
Emrahi, L., Hosseinzadeh, H., & Toufan, M. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101471 · Cited by 1
Hypertrophic Cardiomyopathy
Marchesini, M., & Baiocco, E. (2015) · Springer eBooks · doi:10.1007/978-3-319-19926-9_11 · Cited by 1
OBSOLETE: Electrophysiology Approaches for Ventricular Tachycardia
John, R. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.10966-3 · Cited by 1
Exercise testing in hypertrophic cardiomyopathy: A pathophysiological goldmine with protean clinical implications
Olivotto, I., & Maurizi, N. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.044 · Cited by 1
Electrophysiology Approaches for Ventricular Tachycardia
John, R. M., & Stevenson, W. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.10966-4 · Cited by 1
Arrhythmias and Hypertrophic Cardiomyopathy
Nair, K., CAMERON, D. A., Moravsky, G., & BUTANY, J. W. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_19
The Never Ending Story of Risk Stratification for Sudden Death in Hypertrophic Cardiomyopathy
Christiaans, I., & Wilde, A. A. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.357
Almanac 2011: Cardiomyopathies. the National Society Journals Present Selected Research That Has Driven Recent Advances in Clinical Cardiology
Elliot, P. M., & MOHIDDIN, S. A. (2011) · Acta Informatica Medica · doi:10.5455/aim.2011.19.235-240
Miocardiopatia Hipertrófica: novas metodologias aplicadas ao diagnóstico genético
Vida, D. D. C. D. (2011)
Arrhythmias and Arrhythmia Management in Hypertrophic Cardiomyopathy
Bos, J. M., Ommen, S. R., & Ackerman, M. J. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4978-1_2
Sudden cardiac death – what do we know and how do we prevent it?
Zandecki, Ł., Sadowski, M., Domagała, S., Łętek, A., & Janion, M. (2013) · Medical Studies · doi:10.5114/ms.2013.39984
Sudden cardiac death - what do we know and how do we prevent it? Nagły zgon sercowy - co wiemy i jak zapobiegamy?
Sadowski, M., & Janion, M. (2013)
Sudden Cardiac Death
Kumar, P., & Paul, J. (2013) · InTech eBooks · doi:10.5772/55636
The Potential of Late Gadolinium Enhancement to Serve as a Predictor of Ventricular Arrhythmias in Hypertrophic Cardio-myopathy Patients
Gossios, T. D., Efthimiadis, G. K., Karamitsos, T. D., Zegkos, T., Athyros, V. G., & Karvounis, H. I. (2016) · The Open Hypertension Journal · doi:10.2174/1876526201608010001
19 – Pacing and Defibrillation Use in Pediatric Patients
Motonaga, K., & Dubin, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00019-5 · Cited by 1
Implantable Cardioverter-Defibrillators in Inherited Arrhythmia Syndromes
Nordkamp, L. R. A. O., & Wilde, A. A. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00021-3
CARDIOVASCULAR HEMODYNAMICS AND SPECIFICS OF 24-HOUR BP PROFILE IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND INADEQUATE BP REACTION ON PHYSICAL EXERTION
Хашиева, Ф. М., Демкина, А. Е., Krylova, N. S., Анатольевна, К. Е., & Потешкина, Н. Г. (2015) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2015-5-76-81
CMR in Phenotyping the Arrhythmic Substrate
Morgan, R. B., & Kwong, R. Y. K. (2017) · Current Cardiovascular Imaging Reports · doi:10.1007/s12410-017-9416-2
Correlação entre arritmias potencialmente malignas e a densidade de fibrose detectada pela tomografia computadorizada em coração de pacientes com cardiomiopatia hipertrófica
Habib, R. G. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.98.2016.tde-07102016-072738
High-risk electrocardiogram patterns in patients with syncope managed in the emergency department
Tomaino, M., Unterhuber, M., & Rosso, A. D. (2018) · Emergency Care Journal · doi:10.4081/ecj.2018.7570
Análise exômica em pacientes portadores de cardiomiopatia hipertrófica
de Castro, L. R. (2016) · doi:10.11606/t.98.2016.tde-26042016-090654
Imaging and Mapping of Arrhythmias in Hypertrophic Cardiomyopathy
Link, M. S., Phelan, C., Aljaabari, M., & Estes, N. A. M. (2019) · doi:10.1002/9781119152637.ch62
Diagnóstico y estudio de cardiopatías infrecuentes: multimodalidad – miocardiopatía hipertrófica
Torres-Matiz, J. A., & Carvajal-Rivera, J. J. (2019) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2019.05.001
The Sudden Death of Young Persons-Epidemiology, Causes and Risk Factors
(2017) · Archives of Epidemiology · doi:10.29011/2577-2252.000005
Inherited Cardiomyopathies
Teekakirikul, P., Ho, C. Y., & Seidman, C. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00053-7
Almanac 2014: cardiomyopathies
Guttmann, O. P., MOHIDDIN, S. A., & Elliot, P. M. (2015) · Cor et Vasa · doi:10.1016/j.crvasa.2015.01.002
Interdisciplinary approach to surgical treatment for patients with hypertrophic obstructive cardiomyopathy
Rudenko, K. V., Nevmerzhytska, L. O., Kozhanov, M., Tregubova, M., & Danchenko, P. A. (2021) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2021.4.232632
Almanac 2011: Cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
Elliot, P. M., & MOHIDDIN, S. A. (2012) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2012.02.008
Hypertrophic Cardiomyopathy
Tanaka, H. (2018) · Springer eBooks · doi:10.1007/978-981-10-1993-7_10
Almanac 2011: Cardiomyopathies. The national society journals present selected research that has driven recent advances in clinical cardiology
Elliot, P. M., & MOHIDDIN, S. A. (2012) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2012.02.003
Cardiomyopathies the national society journals present selected research that has driven recent advances in clinical cardiology
Elliot, P. M., & MOHIDDIN, S. A. (2012) · Srce i krvni sudovi · doi:10.5937/siks1203174e
Impaired Left Ventricular Contractile Reserve in Patients With Hypertrophic Cardiomyopathy and Abnormal Blood Pressure Response: A Stress Echocardiographic Study
Takeoka, M., Yamano, M., Honda, S., Sakai, C., & Kawasaki, T. (2022) · Cureus · doi:10.7759/cureus.32145
Avaliação de variáveis ecocardiográficas associadas ao resultado da ablação septal por radiofrequência na miocardiopatia hipertrófica obstrutiva
Shinzato, M. H. (2022) · doi:10.11606/d.98.2022.tde-26062023-151733
Harmful Heritage
de Brouwer, R. (2024) · doi:10.33612/diss.1005002804
Guías mexicanas 2024 para el diagnóstico y tratamiento de la miocardiopatía hipertrófica
Llamas‐Esperón, G. A., Berrios-Bárcenas, E. A., Cossío-Aranda, J. E., Guerra-López, A., Magaña‐Serrano, J. A., Iturralde-Torres, P., Lara-Vargas, J. A., Meave‐González, A., Rosas, E. A., Ilazarra-Lomelí, H., et al. (2025) · Archivos de cardiología de México · doi:10.24875/acm.m25000098
Sudden cardiac death risk in hypertrophic cardiomyopathy: New insights, persistent dilemmas
Wilde, A. A. M., & Amin, A. S. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.03.1987
(Sudden cardiac death in hypertrophic cardiomyopathy)
Jenšovský, M., Puchnerová, V., Ošťádal, P., & Bonaventura, J. (2025) · Cor et Vasa · doi:10.33678/cor.2025.086
Role of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
Shaikh, K. A., Sadeghpour, A., & Marwaha, B. (2026) · Springer eBooks · doi:10.1007/978-3-032-02269-1_27
Imaging-Based Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy: Current Evidence and Clinical Perspectives
Pardo, È. R., Sóñora-López, S., Casas, G., Ceballos, M. S., Videla, L. S., Freire, J. L., Teixidó‐Turà, G., González, I. F., & Rodríguez-Palomares, J. F. (2026) · Medical Sciences · doi:10.3390/medsci14030390 · Cited by 1

Authors: Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M.
Affiliations: Amsterdam UMC Location University of Amsterdam (NL)
Erasmus MC (NL)
Corresponding author: Wilde, Arthur A.M.
ORCID: Christiaans, Imke
Birnie, Erwin
Bonsel, Gouke J.
Wilde, Arthur A.M.
Venue: EP Europace
Publisher: Oxford University Press (OUP)
Published: 2010-01-29
Volume: 12
Issue: 3
Pages: 313-321
ISSN: 1099-5129 (ISSN-L)
1532-2092
DOI: 10.1093/europace/eup431
OpenAlex: W2120813609
Cited by: 176
References: 69
Citations by year: 2026: 3 · 2025: 10 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 18 · 2018: 20 · 2017: 13 · 2016: 13 · 2015: 13 · 2014: 8 · 2013: 16 · 2012: 15
FWCI: 2.61
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: other-oa
Locations: EP Europace (publishedVersion)
PubMed (publishedVersion)
Pure Amsterdam UMC (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, sudden cardiac death, risk stratification, left ventricular outflow tract obstruction, left ventricular hypertrophy, ventricular tachycardia, syncope, family history of sudden death, blood pressure response, cardiac arrest
MeSH terms: Cardiomyopathy, Hypertrophic, Humans, Prognosis, Risk Factors, Death, Sudden, Cardiac, Practice Guidelines as Topic, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks